TD Asset Management
KRTX

TD Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

TD Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-189,340
Closed -$59.9M – 1456
2023
Q4 		$59.9M Sell
189,340
-38,378
-17% -$7.46M 0.06% 265
2023
Q3 		$38.5M Buy
227,718
+79,291
+53% +$14.9M 0.05% 300
2023
Q2 		$32.2M Buy
148,427
+8,492
+6% +$1.82M 0.04% 347
2023
Q1 		$25.4M Buy
139,935
+39,254
+39% +$7.51M 0.03% 395
2022
Q4 		$19.8M Buy
100,681
+23,900
+31% +$5.12M 0.02% 434
2022
Q3 		$17.2M Buy
76,781
+36,810
+92% +$7.45M 0.02% 449
2022
Q2 		$5.06M Sell
39,971
-6,500
-14% -$747K 0.01% 769
2022
Q1 		$5.89M Sell
46,471
-776
-2% -$87.4K 0.01% 789
2021
Q4 		$6.19M Buy
47,247
+7,337
+18% +$948K 0.01% 808
2021
Q3 		$4.88M Buy
39,910
+1,900
+5% +$219K 0.01% 822
2021
Q2 		$4.34M Buy
38,010
+992
+3% +$116K ﹤0.01% 866
2021
Q1 		$4.45M Buy
37,018
+8,581
+30% +$972K 0.01% 862
2020
Q4 		$2.89M Hold
28,437
– – ﹤0.01% 930
2020
Q3 		$2.2M Buy
28,437
+1,500
+6% +$128K ﹤0.01% 883
2020
Q2 		$3M Buy
26,937
+600
+2% +$52.2K ﹤0.01% 782
2020
Q1 		$1.9M Sell
26,337
-400
-1% -$34.2K ﹤0.01% 849
2019
Q4 		$2.01M Buy
26,737
+3,806
+17% +$167K ﹤0.01% 928
2019
Q3 		$374K Buy
+22,931
New +$446K ﹤0.01% 1222

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

TD Asset Management's KRTX Position: Q1 2024 in Review

TD Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 189,340 shares — an estimated $59.9M sold.

TD Asset Management first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $59.9M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • TD Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • TD Asset Management sold 189,340 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $59.9M.
  • TD Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • TD Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $59.9M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on TD Asset Management's 13F filing for Q1 2024, filed 8 May 2024.